MX2012006353A - Tratamiento de enfermedades infecciosas. - Google Patents

Tratamiento de enfermedades infecciosas.

Info

Publication number
MX2012006353A
MX2012006353A MX2012006353A MX2012006353A MX2012006353A MX 2012006353 A MX2012006353 A MX 2012006353A MX 2012006353 A MX2012006353 A MX 2012006353A MX 2012006353 A MX2012006353 A MX 2012006353A MX 2012006353 A MX2012006353 A MX 2012006353A
Authority
MX
Mexico
Prior art keywords
alkyl
tonabersat
formula
analogue
hydrogen
Prior art date
Application number
MX2012006353A
Other languages
English (en)
Spanish (es)
Inventor
Peter Blower
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Publication of MX2012006353A publication Critical patent/MX2012006353A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2012006353A 2009-12-03 2010-12-03 Tratamiento de enfermedades infecciosas. MX2012006353A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26623409P 2009-12-03 2009-12-03
PCT/GB2010/052020 WO2011067607A1 (fr) 2009-12-03 2010-12-03 Traitement de maladies infectieuses

Publications (1)

Publication Number Publication Date
MX2012006353A true MX2012006353A (es) 2012-06-27

Family

ID=44115623

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006353A MX2012006353A (es) 2009-12-03 2010-12-03 Tratamiento de enfermedades infecciosas.

Country Status (7)

Country Link
EP (1) EP2506847A1 (fr)
CN (1) CN102770134A (fr)
AU (1) AU2010325755A1 (fr)
CA (1) CA2782631A1 (fr)
MX (1) MX2012006353A (fr)
RU (1) RU2012124838A (fr)
WO (1) WO2011067607A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2870148A1 (fr) 2012-07-03 2015-05-13 Proximagen Limited Composés promédicaments
JP6898848B2 (ja) 2014-09-19 2021-07-07 メモリアル スローン ケタリング キャンサー センター 脳転移を治療するための方法
BR112018000707A2 (pt) 2015-07-15 2018-09-18 Theranexus ?composições terapêuticas e produto de combinação?
WO2021051015A1 (fr) * 2019-09-13 2021-03-18 Auckland Uniservices Limited Compositions et méthodes pour sauver la structure et la fonction rétiniennes et choroïdiennes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0673374T3 (da) * 1992-12-11 2000-07-31 Smithkline Beecham Corp Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper
DE69524871T2 (de) 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
US20090130128A1 (en) * 2007-08-17 2009-05-21 Alberte Randall S Antiinfective Proanthocyanidin Compounds and Methods of Use Thereof

Also Published As

Publication number Publication date
CA2782631A1 (fr) 2011-06-09
RU2012124838A (ru) 2014-01-10
AU2010325755A1 (en) 2012-06-21
EP2506847A1 (fr) 2012-10-10
WO2011067607A1 (fr) 2011-06-09
CN102770134A (zh) 2012-11-07

Similar Documents

Publication Publication Date Title
JP3207816B2 (ja) 点鼻液剤
CZ299348B6 (cs) Aerosolový prostredek
IL178815A (en) Treatment of respiratory disease
MX2012006353A (es) Tratamiento de enfermedades infecciosas.
CA2726878A1 (fr) Nouveaux traitements
US20200054595A1 (en) EGCG-Palmitate Compositions and Methods of Use Thereof
MX2010013312A (es) Tratamientos novedoos.
EP2608847B1 (fr) Théobromine combinée à un expectorant ou à un mucolytique et son utilisation en thérapie
AU2003240113A1 (en) Formulation of nefopam and its use in the treatment of pain
US20120309822A1 (en) Treatment of infectious diseases
KR20050098309A (ko) 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
MX2012006352A (es) Tratamiento de alodinia e hiperalgesia.
JP2013512887A (ja) 感染症の治療
EP3097915B1 (fr) Formulation de suspension améliorée d'un corticostéroïde pour administration par inhalation
CA2901208A1 (fr) Agents analgesiques oculaires topiques
WO2021207271A1 (fr) Mimétiques de glutathion peroxydase de type organosélénium pour le traitement de maladies pulmonaires inflammatoires
JP2001270826A (ja) 皮膚疾患治療・予防用外用剤
JP2013512888A (ja) 異痛および痛覚過敏の治療
AU2015200651B2 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
CN118001410A (zh) 组合物及其用途
EP1393727B1 (fr) Agent curatif pour myelopathies
KR100384346B1 (ko) 엘레트립탄 헤미술페이트 및 카페인을 포함하는 약제학적조성물
KR20050036166A (ko) 인두내 염증 치료용 암브록솔

Legal Events

Date Code Title Description
FA Abandonment or withdrawal